Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung

British Journal of Cancer

Volumn 77, Issue 2, 1998, Pages 260-269

  Bjorkqvist A M ^a   Tammilehto, L ^b   Nordling, S ^a   Nurminen, M ^b   Anttila, S ^b   Mattson, K ^c   Knuutila, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Comparative genomic hybridization; Gains; Losses; Lung carcinoma; Mesothelioma

Indexed keywords

ANAPLASTIC CARCINOMA; ARTICLE; DISCRIMINANT ANALYSIS; DNA DETERMINATION; DNA HYBRIDIZATION; GENE LOCATION; GENE LOSS; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0031974484     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.42     Document Type: Article

References (39)

1. Björkqvist A-M, Tammilehto L, Anttila S, Mattson K and Knuutila S (1997) Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer 75: 523-527
2. Brown RW, Clark GM, Tandon AK and Allred DC (1993) Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 24: 347-354
3. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM and Mandel EM (1982) Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Internal Med 96: 746-755
4. Cline MJ and Battifora H (1987) Abnormalities of protoonocogenes in non-small cell lung cancer, correlations with tumor type and clinical characlcristics. Cancer 60: 2669-2674
5. Doglioni C, Dei Tos AP, Laurino L, Iuzzolini P, Chiarelli C, Celio MR and Viale G (1996) Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 20: 1037-1046
6. Edwards C and Oates J (1995) OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material. J Clin Pathol 48: 626-630
7. Efron B (1983) Estimating the error rate of a prediction rule: improvement on cross-validation. J Am Stat Assoc 78: 36-48
8. Fisher RA (1936) The use of multiple measurements in taxonomic problems. Ann Eug. 7: 179-188
9. Hagemeijer A, Versnel MA, Van Drunen E, Morel M, Bouts MJ, van der Kwast TH and Hoogsteden HC (1990) Cytogenetic analysis of mesothelioma. Cancer Genet Cytogenet 1-28
10. Harrel F, Lee K and Mark K (1996) Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387
11. Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Fursiainen K, Mattson K and Vainio H (1996) Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 88: 1853-1856
12. Isola J, DeVries S, Chu L, Ghazvini S and Waldman F (1994) Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145: 1301-1308
13. Jin Y-s, Mandahl N, Heim S, Schuller H and Mitelman F (1988) Isochromosomes 1(8q) or i(9q) in three adenovarcinomas of the lung. Cancer Genet Cytogenet 33: 11-17
14. Johnson NL and Kotz S (1969) Discrete Distributions. Wiley: New York
15. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821
16. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10: 231-243
17. Kivipensas P, Björkqvist A-M, Karhu R, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Kallioniemi O-P and Knuutila S (1996) Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization. Cancer Genet Cytogenet 89: 7-13
18. Lukeis R, Irving L, Garson M and Hasthorpe S (1990) Cytogenetics of non-small cell lung cancer: analysis of consistent non-random abnormalities. Genes Chromoson Cancer 2: 16-124
19. Lukeis R, Ball D, Irving L, Garson OM and Hasthorpe S (1993) Chromosome abnormalities in non-small cell lung cancer pleural effusions: cytogenetic indicators of disease subgroups. Genes Chromosom Cancer 8: 262-269
20. Mahalanobis PC (1936) On the generalized distance in statistics. Proc Natl Inst Sci India 12: 49-55
21. Metcalf RA, Welsh JA, Bennett WP, Seddon MB, Lehman TA, Pelin K, Linnainmaa K, Tummilehto L, Mattson K, Gerwin BL and Harris CC (1992) p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res 52: 2610-2615
22. Miettinen M and Kovatich AJ (1995) HBME-1 a monoclonal antibody useful in the ditterential diagnosis ot mesothelioma, adenocarcinoma, and sott-tissue and bone tumors. Appl Immunohistochem 3: 115-122
23. Miettinen O and Nurminen M (1985) Comparative analysis of two rates. Stat Med 4: 213-226
24. Miller SA, Dykes DD and Polesky HF (1988) A simple salting out procedure for extracting DNAs from human nucleated cells. Nucleic Acids Res 16: 1215
25. Monni O, Joensuu H, Franssila K and Knuutila S (1996) DNA copy number changes in diffuse large B-cell lymphoma - comparative genomic hybridization study. Blood 87: 5269-5278
26. Pellomäki P, Alfthan O and de la Chapelle A (1991) Oncogenes in human testicular cancer: DNA and RNA studies. Br J Cancer 63: 851-858
27. Pisani RJ, Colby TV and Williams DE (1988) Malignant mesothelioma of the pleura. Mayo Clin Proc 63: 1234-1244
28. Ridanpää M, Karjalainen A, Anttila S, Vainio H and Husgafvel-Pursiainen K (1994) Genetic allerations in p53 and K-ras in lung cancer in relation to histopathology of the tumor and smoking history of the patient. Int J Oncol 5: 1109-1117
29. Skov BG, Lauritzen AF, Hirsh FR, Skov T and Nielsen HW (1994) Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies. Histopathology 25: 431-437
30. Slebos RJ, Evers SG, Wagenaar SS and Rodenhuis S (1989) Cellular protooncogenes are intrequently amplified in untreated non-small cell lung cancer. Br J Cancer 59: 76-80
31. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM and Testa JR (1993) Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53: 4349-4355
32. Testa JR, Siegfried JM, Liu Z, Hunt JD, Feder MM, Litwin S, Zhou J-Y, Taguchi T and Keller SM (1994) Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval. Genes Chromosom Cancer 11: 178-194
33. Tiainen M, Tammilehto L, Rautonen J, Tuomi T, Mattson K and Knuutila S (1989) Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Br J Cancer 60: 618-626
34. Van der Meeren A, Seddon MB, Kispert J, Harris CC and Gerwin BI (1993) Lack of expression of the retinoblastoma gene is not frequently involved in the genesis of human mesothelioma. Eur Respir Rev 3: 177-179
35. Venables WN and Ripley BD (1994) Modern Applied Statistics with S-plus. Springer: New York
36. Wagner JC, Sleggs CA and Marchand P (1960) Diffuse pleural mesotheliomas and asbestos exposure in the Northwestern Cape Province. Br J Ind Med 17: 260-271
37. Weiss LM and Batlifora H (1993) The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma. Hum Pathol 24: 345-346
38. Xiao S, Li D, Corson JM, Vijg J and Fletcher JA (1995a) Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res 55: 2968-2971
39. Xiao S, Li D, Vijg J, Sugartaker DJ, Corson JM and Fletcher JA (1995) Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene 11: 511-515